Sequences of cytotoxic T-lymphocyte epitopes in the Epstein-Barr virus (EBV) nuclear antigen-3B gene in a Japanese population with or without EBV-positive lymphoid malignancies
H. Kanno et al., Sequences of cytotoxic T-lymphocyte epitopes in the Epstein-Barr virus (EBV) nuclear antigen-3B gene in a Japanese population with or without EBV-positive lymphoid malignancies, INT J CANC, 88(4), 2000, pp. 626-632
Latent infection antigens of EBV, including EBV nuclear antigens (EBNAs) an
d latent membrane proteins, are expressed in latently infected and immortal
ized B cells but work as target antigens for host cytotoxic T-lymphocyte (C
TL) responses in an HLA class I-restricted manner. Among these latent antig
ens, the immunodominant CTL epitopes in EBNA3B (EBNA3B 399-408 and EBNA3B 4
16-424) are well characterized, Mutations and strain differences in these s
equences, compared to the prototype A sequence, reduce CTL responses to lat
ently infected B cells, These EBNA3B CTL epitopes in the normal Japanese po
pulation and in 2 lymphoid neoplasias, pyothorax-associated lymphoma (PAL)
and nasal natural killer-cell lymphoma, were directly sequenced by PCR. Mos
t EBV in peripheral blood leukocytes (PBLs) from healthy Japanese donors ex
hibited the prototype A sequence, with mutations in approximately 20% (3/16
), The sequence of EBNA3B CTL epitopes in lymphoma tissue was obtained in 6
PAL cases, and 5 exhibited mutations or strain differences compared to the
prototype A sequence. Furthermore, the EBNA3B sequence in PAL tissue was d
ifferent from that in PBLs of the same patient or I of the sequences found
in PBLs, However, the EBNA3B gene in nasal lymphoma tissues exhibited predo
minantly the prototype A sequence. Because PAL cells expressed EBNA3B mRNA,
detected by RT-PCR, but nasal lymphoma cells did not, mutations and strain
differences of the sequences of EBNA3B CTL epitopes were specific findings
in EBNA3B-positive lymphomas. (C) 2000 Wiley-Liss, Inc.